CME Stock Analysis: Buy, Sell, or Hold?

CME - CME Group Inc.

SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES
$289.06
-0.77 (-0.27%) ▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 04, 2026 3d

Get Alerted When CME Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: CME shows positive signals but monitor for confirmation. Market pricing in 1.6% growth. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$344.06
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$213.63
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CME is currently trading at $289.06, which is considered extended relative to its 30-day fair value range of $268.87 to $282.43. The stock's valuation (Forward PE: 24.7) is in line with its historical norms (23.6). At these levels, the market is pricing in 1.6% annual earnings growth.

Technical Outlook: Technically, CME is in a uptrend. The price is approaching resistance at $291.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: CME has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $268.87 - $282.43
Company Quality Score 65/100 (BUY)
Volume Confirmation HIGH
Confidence Score 60.5%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($290.40)
  • BULLISH: Expecting earnings turnaround to 1.6% growth with -3.0% revenue growth

Fair Price Analysis

30-Day Fair Range $268.87 - $282.43
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $270.87
Resistance Level $291.76
Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 24.71
Wall Street Target $290.40 (+0.2%)
Revenue Growth (YoY) -3.0%
Earnings Growth (YoY) -0.4%
Profit Margin 59.0%
Valuation Premium vs History +1.6% premium
PE vs Historical 24.7 vs 23.6 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +1.6% (market-implied from PE analysis)
1-Year Target $294.47 (+2%)
2-Year Target $299.18 (+3%)
3-Year Target $303.97 (+5%)
3-Yr Target (if PE normalizes) (PE: 25→24) PE COMPRESSION $290.26 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 24.7, Growth: 4.9%) $334.32 (+15%)
Base: (SPY PE: 22.3, Growth: 4.9%) $301.65 (+4%)
Bear: (PE: 19.0, Growth: 4.9%) $256.41 (-12%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (28x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 27.69 | Current EPS (TTM): $10.33
Bull Case $357.21 (+24%)
Analyst growth 13.5%, PE expands to 30.5
Base Case $324.74 (+12%)
Market implied 13.5%, PE stable at 27.7
Bear Case $194.51 (-33%)
Severe decline -20.0%, PE contracts to 23.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 12:51 PM ET
Data refreshes hourly during market hours. Next update: 1:51 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
4
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna BUY 2025-09-29
William R Shepard BUY 12 shares 2025-09-25
William R Shepard BUY 262 shares 2025-09-25

Top Rated Financial Data & Stock Exchanges Stocks

Top-rated stocks in Financial Data & Stock Exchanges by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SPGI
S&P Global Inc
STRONG BUY
26 analysts
$619 61 BUY
COIN
Coinbase Global Inc
HOLD
29 analysts
$345 50 HOLD
MCO
Moodys Corporation
BUY
25 analysts
$576 62 BUY
ICE
Intercontinental Exchang…
STRONG BUY
18 analysts
$192 63 BUY
MSCI
MSCI Inc
BUY
19 analysts
$660 69 BUY

Advanced CME Option Strategies

Professional options setups generated by AI based on today's CME price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CME

CME Technical Chart CME Price Prediction CME Earnings Date CME Investment Advisor CME Fair Price Analyzer CME Options Advisor CME Options Chain CME Options Analysis CME Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals